• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Novartis

Novartis

Novartis AG ADR NVS 3 Star

Last Price$90.15Day Change (%)1.02%
Open Price$89.81Day Change ($)0.91
Day Range89.69–90.2752-Week Range76.36–95.50

As of Fri 10/24/2014 06:39 PM EST | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. EU Approves Acquisition of Novartis Animal Health Division by Eli Lilly

    EU Approves Acquisition of Novartis Animal Health Division by Eli Lilly

  2. ImmunoGen, Inc. Reports First Quarter Fiscal Year 2015 Financial Results

    ImmunoGen, Inc. Reports First Quarter Fiscal Year 2015 Financial Results

  3. Oxford Biomedica Inks New Collaboration Pact with Novartis

    Oxford Biomedica Inks New Collaboration Pact with Novartis

  4. Research and Markets: Global Pancreatic Cancer Market 2014-2018: Key Vendors are Celgene, Eli Lilly, F. Hoffmann-La Roche, Novartis and Pfizer

    Research and Markets: Global Pancreatic Cancer Market 2014-2018: Key Vendors are Celgene, Eli Lilly, F. Hoffmann-La Roche, Novartis and Pfizer

  5. Blockbusters Differentiate Novartis

    The company's diverse operating divisions and robust pipeline should lead to steady growth.

  6. Research and Markets: Global Partial Seizure Clinical Trials Review, H2, 2014

    Research and Markets: Global Partial Seizure Clinical Trials Review, H2, 2014

  7. Research and Markets: Competitor Analysis: Ebola Virus Vaccines and Therapeutics Report 2014 Featuring Over 30 Institutions

    Research and Markets: Competitor Analysis: Ebola Virus Vaccines and Therapeutics Report 2014 Featuring Over 30 Institutions

  8. Looking for Bubbles Part One: A Statistical Approach

    Novartis NVS announced Friday that it is removing Zelnorm for irritable bowel syndrome from the U.S. market at the request of the Food and Drug Administration. We think Zelnorm could eventually return to pharmacy shelves in the United States, but we have drastically reduced our estimate of sales ...

  9. Research and Markets: Global Biological Drugs Market Outlook 2020

    Research and Markets: Global Biological Drugs Market Outlook 2020

  10. Research and Markets: Fallopian Tube Cancer - Pipeline Review, H2 2014

    Research and Markets: Fallopian Tube Cancer - Pipeline Review, H2 2014

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.